Literature DB >> 19395955

The use of early intervention to prevent postoperative complications.

Shaman Jhanji1, Rupert M Pearse.   

Abstract

PURPOSE OF REVIEW: The incidence of complications following major surgery is surprisingly high. Patients who develop complications suffer a reduction in long-term survival. This review aims to explore recent advances in the management of surgical patients aimed at preventing postoperative complications. RECENT
FINDINGS: Identifying patients prior to surgery who are at risk of a poor outcome remains challenging. There are a number of scoring systems to assist clinical risk assessment. Recent work has investigated the use of plasma biomarkers for perioperative risk prediction. Therapies aimed at reducing complication rates by attempting to improve tissue oxygen delivery include goal-directed haemodynamic therapy and postoperative noninvasive ventilation. The role of perioperative beta-adrenoceptor antagonists remains unclear. Other important measures include the use of a surgical safety checklist and thromboprophylaxis.
SUMMARY: Current systems for the identification and treatment of high-risk surgical patients are inadequate. Further research is required to establish the optimal approach to the identification and management of the high-risk surgical patient.

Entities:  

Mesh:

Year:  2009        PMID: 19395955     DOI: 10.1097/MCC.0b013e32832c4a7e

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  6 in total

1.  Goal-Directed Fluid Therapy: What the Mind Does Not Know, the Eye Cannot See.

Authors:  Joshua A Bloomstone; Randal O Dull; Lais H C Navarro
Journal:  Turk J Anaesthesiol Reanim       Date:  2017-02-01

Review 2.  Standard perioperative management in gastrointestinal surgery.

Authors:  Marian Grade; Michael Quintel; B Michael Ghadimi
Journal:  Langenbecks Arch Surg       Date:  2011-03-30       Impact factor: 3.445

3.  Has goal directed fluid therapy and glycocalyx a role in enhanced recovery after anesthesia?

Authors:  Abdelazeem Eldawlatly
Journal:  Saudi J Anaesth       Date:  2017 Oct-Dec

4.  Outcome of Noncardiac Surgical Patients Admitted to a Multidisciplinary Intensive Care Unit.

Authors:  Pradeep Kumar; M K Renuka; M S Kalaiselvan; A S Arunkumar
Journal:  Indian J Crit Care Med       Date:  2017-01

Review 5.  Postoperative pain management in non-traumatic emergency general surgery: WSES-GAIS-SIAARTI-AAST guidelines.

Authors:  Federico Coccolini; Francesco Corradi; Massimo Sartelli; Raul Coimbra; Igor A Kryvoruchko; Ari Leppaniemi; Krstina Doklestic; Elena Bignami; Giandomenico Biancofiore; Miklosh Bala; Ceresoli Marco; Dimitris Damaskos; Walt L Biffl; Paola Fugazzola; Domenico Santonastaso; Vanni Agnoletti; Catia Sbarbaro; Mirco Nacoti; Timothy C Hardcastle; Diego Mariani; Belinda De Simone; Matti Tolonen; Chad Ball; Mauro Podda; Isidoro Di Carlo; Salomone Di Saverio; Pradeep Navsaria; Luigi Bonavina; Fikri Abu-Zidan; Kjetil Soreide; Gustavo P Fraga; Vanessa Henriques Carvalho; Sergio Faria Batista; Andreas Hecker; Alessandro Cucchetti; Giorgio Ercolani; Dario Tartaglia; Joseph M Galante; Imtiaz Wani; Hayato Kurihara; Edward Tan; Andrey Litvin; Rita Maria Melotti; Gabriele Sganga; Tamara Zoro; Alessandro Isirdi; Nicola De'Angelis; Dieter G Weber; Adrien M Hodonou; Richard tenBroek; Dario Parini; Jim Khan; Giovanni Sbrana; Carlo Coniglio; Antonino Giarratano; Angelo Gratarola; Claudia Zaghi; Oreste Romeo; Michael Kelly; Francesco Forfori; Massimo Chiarugi; Ernest E Moore; Fausto Catena; Manu L N G Malbrain
Journal:  World J Emerg Surg       Date:  2022-09-21       Impact factor: 8.165

6.  Influence of early goal-directed therapy using arterial waveform analysis on major complications after high-risk abdominal surgery: study protocol for a multicenter randomized controlled superiority trial.

Authors:  Leonard Montenij; Eric de Waal; Michael Frank; Paul van Beest; Ardine de Wit; Cas Kruitwagen; Wolfgang Buhre; Thomas Scheeren
Journal:  Trials       Date:  2014-09-16       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.